Pharm-Care Tadulako®: Web-Based Design Application to Improve Pharmaceutical Care Services
Abstract
Pharmaceutical services recently require new ideas and innovation to provide maximum benefit concerning the pharmacological treatments of patients and taking responsibility for the process of monitoring their therapy. One of the efforts proposed to be implemented by pharmacists is the pharmaceutical care program which is designed to ensure pharmacists are able to monitor safe and effective medication use and also to provide timely access to medicines for the population. Moreover, the application of eHealth in terms of technology is expected to be effective, networked, patient-centered, and accessible for patients. Therefore, Pharm-Care Tadulako® which is a personalized eHealth application designed with key features of pharmaceutical care to enhance communication between pharmacists and patients is presented in this study. Some of the services designed to be provided by this application include electronic medical records, drug reminders, pharmaceutical messenger, clinical data monitoring, and medication analysis. The application was designed using Software Development Life Cycle (SDLC) Waterfall, after which a pilot study was conducted at four pharmacies in Palu City, Centre of Sulawesi, Indonesia, using 30 patients who volunteered willingly to participate in the experiment. It was discovered that 65% out of the 30 patients were aged 26-45 years old out of which 36% were observed to be suffering from hypertension. The Pharm-Care Tadulako® application was found to have a good impact on pharmacists during the process of providing pharmaceutical care services to patients while they were able to monitor their treatment through the five main features of the application.
Keywords
Full Text:
PDFReferences
Perri A, Peruffo E. Family business and technological innovation: Empirical insights from the Italian pharmaceutical industry. Family Business and Technological Innovation: Empirical Insights from the Italian Pharmaceutical Industry. 2017.
Almalki M, Gray K, Sanchez FM. The use of self-quantification systems for personal health information: big data management activities and prospects. Health Information Science and Systems. 2015;3(S1).
Evangelatos N, Satyamoorthy K, Brand A. Personalized health in a public health perspective. Vol. 63, International Journal of Public Health. 2018.
Allemann SS, Van Mil JWF, Botermann L, et al. Pharmaceutical care: The PCNE definition 2013. International Journal of Clinical Pharmacy. 2014;36(3).
Kehrer JP, Eberhart G, Wing M, Horon K. Pharmacy’s role in a modern health continuum. Canadian Pharmacists Journal. 2013;146(6).
Karatzanis I, Kontogiannis V, Spanakis EG, et al. Empowering patients through a patient portal for an improved diabetes management. In: Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering, LNICST. 2013.
Berrewaerts J, Delbecque L, Orban P, Desseilles M. Patient participation and the use of ehealth tools for pharmacoviligance. Frontiers in Pharmacology. 2016 Vol. 7.
Car J, Tan WS, Huang Z, Sloot P, Franklin BD. eHealth in the future of medications management: Personalisation, monitoring and adherence. BMC Medicine. 2017;15(1).
Cheema E, Alhomoud FK, AL-Deen Kinsara AS, et al. The Impact Of Pharmacists-Led Medicines Reconciliation On Healthcare Outcomes In Secondary Care: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials. PLoS ONE. 2018;13(3).
Knoer SJ, Eck AR, Lucas, AJ. Review Of American Pharmacy: Education, Training, Technology, And Practice. Journal of Pharmaceutical Health Care and Sciences. 2016; 2(1), 1–7. https://doi.org/10.1186/s40780-016-0066-3
Car J, Tan WS, Huang Z, et al. Ehealth in The Future of Medications Management: Personalisation, Monitoring And Adherence. BMC Medicine. 2017; 15(1), 1–9. https://doi.org/10.1186/s12916-017-0838-0
Aljamal SM, Alrowili MS. Clinical Pharmacy, Pharmaceutical Care, and The Quality of Drug Therapy. Pharmacotherapy. 2019; 24(11),1491–1498. https://doi.org/10.1592/phco.24.16.1491.50950
Kang, et al. Satisfaction And Expressed Needs Of Pharmaceutical Care Services And Challenges Recognized By Patients In South Korea. Patient Preference And Adherence. 2017; 1381–1388, 11. https://doi.org/10.2147/PPA.S141562
Spanakis M, Sfakianakis S, Kallergis G, Spanakis, EG. Pharmacta : Personalized Pharmaceutical Care Ehealth Platform For Patients And Pharmacists. Journal of Biomedical Informatics. September 2019; 100; 103336. https://doi.org/10.1016/j.jbi.2019.103336
Santoso LO. Doctor's Perception of The Role of Pharmacist in Pharmaceutical Services at The Naval Hospital Dr. Ramelan Surabaya. Scientific Journal of Students Surabaya University. 2013; 2(2), 1–13
Pratiwi H, Mustikaningtias I, Widyartika, et al. Analysis of Public Perception of the Role of Pharmacists in Pharmaceutical Services in Pharmacies of Sokaraja Subdistrict Baturraden Sumbang and Kedungbanteng. JPSCR: Journal of Pharmaceutical Science and Clinical Research. 2020; 5(1), 33. https://doi.org/10.20961/jpscr.v5i1.39273
Wahid, AA. Waterfall Method Analysis for Information System Development. Journal of Informatics and Management Sciences STMIK. November 2020; 1–5. https://www.researchgate.net/profile/Aceng_Wahid/publication/346397070_Analisis_Metode_Waterfall_Untuk_Pengembangan_Sistem_Informasi/links/5fbfa91092851c933f5d76b6/Analisis-Metode-Waterfall-Untuk-Pengembangan-Sistem-Informasi.pdf
Zaliluddin, D. Web-Based Sales Information System Design (Case Studies in Newbiestore). INFOTECH Journal. 2018; 4(1), 24–27.
Frederic E, Christian L, Katherine B. A Mobile Phone App for Bedside Nursing Care: Design and Development Using an Adapted Software Development Life Cycle Model. JMIR mHealth and uHealth. 2019. doi: 10.2196/12551. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482397/
Gurung G, Shah R, Jaiswal DP. Software Development Life Cycle Models-A Comparative Study. July 2020. https://doi.org/10.32628/CSEIT206410
Khvorostianov N, Elias N, Nimrod G. ‘Without It I Am Nothing’: The Internet In The Lives Of Older Immigrants. New Media and Society. 2011; 14(4), 583–599. https://doi.org/10.1177/1461444811421599
APJII. Penetration and Behaviour of Indonesian Internet Users. 2016. https://apjii.or.id/survei2016/download/4J82Ma1SfGyiAs03j6NhgxY9TlIVKc
World Health Organization. Global Status Report On Noncommunicable Diseases 2014. http://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf;jsessionid=6DA6516D2ED56DF73C8B07A88F7A42D6?sequence=1
Agency for Health Research and Development. Ministry of Health of the Republic of Indonesia: Basic Health Research "RISKESDAS" 2018. https://kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas-2018_1274.pdf
Agency for Health Research and Development. Ministry of Health of the Republic of Indonesia: Basic Health Research "RISKESDAS" 2013.https://pusdatin.kemkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.pdf
World Health Organization. Hypertension. 2021. https://www.who.int/news-room/fact-sheets/detail/hypertension
MIMS Indonesia. MIMS: Drugs Information 2021. https://www.mims.com/indonesia
Laurent S. Antihypertensive drugs. Pharmacol Res [Internet]. 2017;124:116–25. Available from: http://dx.doi.org/10.1016/j.phrs.2017.07.026
Şen S, Demir M, Yiğit Z, et al. Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy. Journal of Cardiovascular Pharmacology and Therapeutics. 2018; 23(4), 318–328. https://doi.org/10.1177/1074248418769054
Fares H, DiNicolantonio JJ, O’Keefe, el al. Amlodipine in hypertension: A first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016; 3(2), 1–7. https://doi.org/10.1136/openhrt-2016-000473
Sattui SE, Gaffo AL. Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Therapeutic Advances in Musculoskeletal Disease, 2016; 8(4), 145–159. https://doi.org/10.1177/1759720X16646703
Xiao Y, Zhang S, Dai N, Fei G, el al. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Gut. 2020; 69(2), 224–230. https://doi.org/10.1136/gutjnl-2019-318365
Pillinger MH, Mandell BF. Therapeutic approaches in the treatment of gout. 2020; 50, 24–30. https://doi.org/10.1016/j.semarthrit.2020.04.010
Ashida K, Sakurai Y, Hori, et al. Randomised clinical trial: Vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Alimentary Pharmacology and Therapeutics. 2016; 43(2), 240–251. https://doi.org/10.1111/apt.13461
DOI: https://doi.org/10.15416/pcpr.v8i2.45759
Refbacks
- There are currently no refbacks.
